The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

被引:0
作者
Ali Afshar-Oromieh
Eleni Avtzi
Frederik L. Giesel
Tim Holland-Letz
Heinz G. Linhart
Matthias Eder
Michael Eisenhut
Silvan Boxler
Boris A. Hadaschik
Clemens Kratochwil
Wilko Weichert
Klaus Kopka
Jürgen Debus
Uwe Haberkorn
机构
[1] University Hospital of Heidelberg,Department of Nuclear Medicine
[2] Clinical Cooperation Unit Nuclear Medicine,German Cancer Research Centre
[3] German Cancer Research Center,Department of Biostatistics
[4] German Cancer Research Centre,National Centre for Tumor Diseases (NCT)
[5] Heidelberg,Division of Radiopharmaceutical Chemistry
[6] German Cancer Research Center,Department of Urology
[7] University Hospital of Heidelberg,Department of Pathology
[8] University Hospital of Heidelberg,Department of Radiation Oncology and Therapy
[9] University Hospital Heidelberg,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷
关键词
Prostate cancer; PET/CT; Positron emission tomography; PSMA; FMCH; FECH;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:197 / 209
页数:12
相关论文
共 95 条
  • [1] Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
  • [2] Ma J(2005)EAU guidelines on prostate cancer Eur Urol 48 546-551
  • [3] Zou Z(2005)Fluorocholine PET/CT in patients with prostate cancer: initial experience Radiology 235 623-628
  • [4] Jemal A(2008)The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer Eur J Nucl Med Mol Imaging 35 976-983
  • [5] Aus G(2008)Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels Eur J Nucl Med Mol Imaging 35 1567-1569
  • [6] Abbou CC(2006)Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection J Urol 176 2014-2018
  • [7] Bolla M(2008)Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 253-263
  • [8] Heidenreich A(2006)Technology insight: monoclonal antibody imaging of prostate cancer Nat Clin Pract Urol 3 216-225
  • [9] Schmid HP(1997)Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium Cancer Res 57 3629-3634
  • [10] Van Poppel H(1998)Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases Urology 52 637-640